The pharmacological treatment of primary aldosteronism.

about

Physiologic tailoring of treatment in resistant hypertension Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.

P2860

Q41451761-5FA3B1CC-E4BF-441E-9809-5B248185A53E Q46394312-430E11AB-316C-4AC7-991D-444DAE604580 Q46724380-FCB4CA42-F466-4924-AA33-59C2B3CE3AD6

P2860

The pharmacological treatment of primary aldosteronism.

Item

http://www.wikidata.org/entity/Q36428495

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

The pharmacological treatment of primary aldosteronism.

@ast

The pharmacological treatment of primary aldosteronism.

@en

type

Item

label

The pharmacological treatment of primary aldosteronism.

@ast

The pharmacological treatment of primary aldosteronism.

@en

prefLabel

The pharmacological treatment of primary aldosteronism.

@ast

The pharmacological treatment of primary aldosteronism.

@en

P1476

The pharmacological treatment of primary aldosteronism.

@en

P2093

Pierre-Marc G Bouloux

http://www.w3.org/2001/XMLSchema#string

Salim Janmohamed

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperaldosteronism: recent concepts, diagnosis, and management

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

Review of surgical management of aldosterone secreting tumours of the adrenal cortex.

Mineralocorticoid hypertension.

Glucocorticoid-remediable aldosteronism.

New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

A review of the medical treatment of primary aldosteronism.

Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift.

P304

563-573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.5.563

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16553572

http://www.w3.org/2001/XMLSchema#string

The pharmacological treatment of primary aldosteronism.

about

P2860

P2860

The pharmacological treatment of primary aldosteronism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698